Available under a Creative Commons Attribution Non-Commercial Share Alike 4.0 International Licence
3.3 HEALTH SCIENCES
The Myopia Outcome Study of Atropine Treatment in Children (MOSAIC) is an investigator-led, double-masked randomised controlled trial of nightly atropine 0.01% eye drops compared to nightly placebo eye drops. A previously published protocol paper outlines the rationale, objective and sample size calculation for the study.1 A total of 250 participants were enrolled in the study and were randomised 2:1 to active treatment and placebo, respectively. This document outlines the plan for analysis of the 24-month outcomes of the MOSAIC.
Lingham, Gareth; Kobia-Acquah, Emmanuel; Loughman, James; and Flitcroft, Daniel Ian, "MOSAIC Clinical Trial Statistical Analysis Plan Primary Analysis v1.2" (2022). Other Resources. 3.
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 International License.